Clinical trial CA209358
Non-Comparative, Two-Cohort, Single-Arm, Open-Label, Phase 1/2 Study of Nivolumab (BMS-936558) in Subjects with Virus-Positive and Virus-Negative Solid Tumors
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2 |
| Academic trial | Non |
| Sponsor | BMS - Bristol Myers Squibb int. |
| EudraCT Identifier | 2015-000230-29 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02488759 |
| Inclusion criteria | ECOG 0 or 1 |
| Last update |